Journal Article (Erratum/Correction) DZNE-2023-00654

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Author Correction: Reverse engineering synthetic antiviral amyloids.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2023
Nature Publishing Group UK [London]

Nature Communications 14(1), 3492 () [10.1038/s41467-023-39293-9]

This record in other databases:    

Please use a persistent id in citations: doi:

Classification:

Contributing Institute(s):
  1. Prion Cell Biology (AG Vorberg)
Research Program(s):
  1. 352 - Disease Mechanisms (POF4-352) (POF4-352)

Appears in the scientific report 2023
Database coverage:
Medline ; Creative Commons Attribution CC BY 4.0 ; DOAJ ; OpenAccess ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Agriculture, Biology and Environmental Sciences ; Current Contents - Life Sciences ; Current Contents - Physical, Chemical and Earth Sciences ; DOAJ Seal ; Essential Science Indicators ; Fees ; IF >= 15 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > BN DZNE > BN DZNE-AG Vorberg
Full Text Collection
Public records
Publications Database


Linked articles:

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Journal Article  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;
Reverse engineering synthetic antiviral amyloids.
Nature Communications 11(1), 2832 () [10.1038/s41467-020-16721-8] OpenAccess  Download fulltext Files  Download fulltextFulltext by Pubmed Central BibTeX | EndNote: XML, Text | RIS


 Record created 2023-06-20, last modified 2023-10-04